News & Events

26 May 2015

Total cost of private access to Perjeta cheaper for Auckland women

Access to Perjeta, a drug for advanced HER2+ breast cancer not yet funded in the NZ public health system, just got a little easier for Auckland women, with Auckland Hospital joining other areas in allowing eligible patients to access Herceptin through the public system while paying for Perjeta privately (Perjeta is used in conjunction with Herceptin and docetaxel (chemotherapy)). …Read more
19 May 2015

Thumbs-down NZ on International Clinical Trials Day

Kiwis have nothing to celebrate this International Clinical Trials Day (tomorrow, Wednesday May 20), says the New Zealand Breast Cancer Foundation. …Read more
20 Apr 2015

Pink Ribbon Breakfast for Research

Registrations are now open for Pink Ribbon Breakfast, with Lorraine Downes asking Kiwis to invite their friends or colleagues to breakfast in May, to raise funds for the New Zealand Breast Cancer Foundation. …Read more
20 Apr 2015

Free Counselling Service Launched

Breast Cancer Foundation NZ has launched a free counselling programme available to women anywhere in New Zealand.
BCFNZ Counselling offers three free one-on-one professional counselling sessions to women at whatever stage of their breast cancer treatment they most need it. …Read more
06 Mar 2015

Laser treatment study a first for NZ

International Lymphoedema Awareness Day - March 6, 2015 …Read more
11 Feb 2015

1000 Tees for 1000 Women

By the end of summer, 1,000 New Zealand women will be diagnosed with breast cancer - an average of eight women diagnosed every day.
…Read more
04 Feb 2015

BCFNZ marks World Cancer Day with grants to improve knowledge and treatment of local cancers

Today, World Cancer Day, Breast Cancer Foundation NZ announced the winners of its research funding contest for studies based on New Zealand’s breast cancer patient registers, awarding six grants for pilot studies to researchers from Auckland, Waikato, Christchurch and Dunedin. …Read more
29 Jan 2015

Promising new advanced TNBC drug accessible for NZ women – at a cost

Results of a small but interesting trial of pembrolizumab (Keytruda) for advanced triple negative breast cancer (TNBC) were released in the USA recently. …Read more

Are we falling behind Australia in terms of access to new cancer drugs? Our reply to PHARMAC's report

In early November PHARMAC published a report investigating whether the differences in the funding of cancer treatments in NZ and Australia impact the health of NZ patients. Below is our response to their report. To read PHARMAC's full report, visit their website. …Read more